Compounds > apomorphine
Page last updated: 2024-08-17

apomorphine and g(m1) ganglioside

apomorphine has been researched along with g(m1) ganglioside in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19905 (50.00)18.7374
1990's3 (30.00)18.2507
2000's1 (10.00)29.6817
2010's1 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fuxe, K; Gustafsson, JA; Ogren, SO; von Euler, G1
Agnati, LF; Biagini, G; Fuxe, K; Grimaldi, R; Merlo Pich, E; Solfrini, V; Toffano, G; Zoli, M1
Jackson, EA; Jenner, P; Marsden, CD1
Emerich, DF; Schmechel, DE; Walsh, TJ1
de Beaurepaire, R; Freed, WJ; Greenberg, JA; Schwarz, SS; Spoor, HE1
Agnati, LF; Fuxe, K; Gustafsson, JA; Hansson, T; von Euler, G1
Agnati, LF; Aldinio, C; Consolazione, A; Fuxe, K; Savoini, G; Toffano, G; Valenti, G1
Frussa-Filho, R; Palermo-Neto, J; Vital, MB1
Frussa-Filho, R; Palermo-Neto, J; Perry, JC; Tufik, S; Vital, MA1
Ba, XH1

Other Studies

10 other study(ies) available for apomorphine and g(m1) ganglioside

ArticleYear
Ganglioside GM1 counteracts the enhancing effects of subacute toluene exposure on apomorphine-induced locomotor activity.
    Toxicology letters, 1992, Volume: 63, Issue:2

    Topics: Animals; Apomorphine; Behavior, Animal; Drug Synergism; G(M1) Ganglioside; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Toluene

1992
Siagoside selectively attenuates morphological and functional striatal impairments induced by transient forebrain ischemia in rats.
    Stroke, 1992, Volume: 23, Issue:2

    Topics: Animals; Apomorphine; Behavior, Animal; Brain; Brain Ischemia; Choice Behavior; Corpus Striatum; Dopamine and cAMP-Regulated Phosphoprotein 32; G(M1) Ganglioside; Germ-Free Life; Hippocampus; Male; Memory Disorders; Nerve Tissue Proteins; Phosphoproteins; Prosencephalon; Rats; Rats, Inbred Strains; Stereotyped Behavior

1992
Behavioural and morphological changes following treatment with GM-1 ganglioside of rats with an electrolytic lesion of the substantia nigra.
    Neuropharmacology, 1989, Volume: 28, Issue:6

    Topics: Animals; Apomorphine; Behavior, Animal; Biogenic Amines; Brain Chemistry; Brain Stem; Chromatography, High Pressure Liquid; Dopamine; G(M1) Ganglioside; Immunohistochemistry; Male; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase

1989
GM1 ganglioside attenuates the behavioral deficits but not the granule cell damage produced by intradentate colchicine.
    Brain research, 1989, Jan-23, Volume: 478, Issue:1

    Topics: Animals; Apomorphine; Avoidance Learning; Colchicine; G(M1) Ganglioside; Hippocampus; Male; Memory; Motor Activity; Rats; Rats, Inbred F344; Retention, Psychology; Scopolamine

1989
Embryonic substantia nigra grafts. Factors controlling behavioral efficacy and reinnervation of the host striatum.
    Annals of the New York Academy of Sciences, 1987, Volume: 495

    Topics: Animals; Apomorphine; Cerebral Cortex; Cerebral Ventricles; Embryo, Mammalian; Estradiol; Female; G(M1) Ganglioside; Haloperidol; Motor Activity; Nerve Regeneration; Ovariectomy; Rats; Substantia Nigra

1987
Ganglioside GM1 treatment prevents the effects of subacute exposure to toluene on N-[3H]propylnorapomorphine binding characteristics in rat striatal membranes.
    Neuroscience letters, 1987, Nov-23, Volume: 82, Issue:2

    Topics: Animals; Apomorphine; Corpus Striatum; G(M1) Ganglioside; Male; Membranes; Osmolar Concentration; Rats; Rats, Inbred Strains; Receptors, Dopamine; Time Factors; Toluene; Tritium

1987
Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro-striatal neurons after different types of lesion.
    Acta physiologica Scandinavica, 1984, Volume: 122, Issue:3

    Topics: Animals; Apomorphine; Behavior, Animal; Corpus Striatum; G(M1) Ganglioside; Gangliosides; Hydroxydopamines; Nerve Regeneration; Neurons; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Rotation; Substantia Nigra; Tyrosine 3-Monooxygenase

1984
Monosialoganglioside increased the in vivo affinity of D2 receptors for apomorphine in supersensitive rats.
    Annals of the New York Academy of Sciences, 1998, Jun-19, Volume: 845

    Topics: Animals; Antipsychotic Agents; Apomorphine; Corpus Striatum; G(M1) Ganglioside; Haloperidol; Kinetics; Metoclopramide; Rats; Receptors, Dopamine D2; Stereotyped Behavior; Substance Withdrawal Syndrome

1998
Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2004, Volume: 14, Issue:2

    Topics: Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Dopamine Agonists; Dopamine Antagonists; Drug Administration Schedule; Drug Interactions; G(M1) Ganglioside; Haloperidol; Immobilization; Locomotion; Male; Rats; Rats, Wistar; Stereotyped Behavior; Substance Withdrawal Syndrome; Time Factors

2004
Therapeutic effects of GM1 on Parkinson's disease in rats and its mechanism.
    The International journal of neuroscience, 2016, Volume: 126, Issue:2

    Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Apomorphine; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Female; G(M1) Ganglioside; Gene Expression Regulation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; RNA, Messenger; Stereotyped Behavior

2016